Adverse Event Reports and Safety Evidence: What Each Can—and Cannot—Show

By the Regenerative Evidence Guide Team

An adverse event report is a description of a health problem someone experienced after using a medical product, filed with a regulator like the FDA. A single report is a data point, not a conclusion — it does not by itself prove the product caused the problem, and it can’t tell you how common that problem actually is.

Say a friend tells you she read online that “12 people had bad reactions” to a regenerative procedure she’s considering. She’s scared, but she isn’t sure what that number means. Were those reports confirmed? Out of how many people who had the procedure? Did the procedure cause the reaction, or did the reaction just happen afterward?

This page walks through what a report can show, what a pattern of reports can show, and what neither one can prove alone — so you can read safety information the way researchers do, and ask sharper questions before you decide anything.

If You’re Having a Reaction Right Now

If you or someone you know is having a medical emergency after any procedure or product, call your local emergency number or go to the nearest emergency room first. Reading about safety data is not a substitute for urgent medical care. Once you are safe, you or your doctor can file a report with the FDA’s MedWatch program, described below.

Three Different Things People Mix Up

Confusion about safety usually comes from treating three different things as one. They are not the same, and mixing them up leads people to draw conclusions the evidence doesn’t support.

• A single report: One person, or their doctor, tells a regulator that something bad happened after a product or procedure. This is a data point, not a conclusion.
• A pattern: Many separate reports describe a similar problem after the same type of product. A pattern can be a legitimate warning sign worth watching closely.
• Proof of cause: Rigorous studies, usually with a comparison group, show a product actually causes a specific outcome more often than would happen without it. This is a much higher bar than a report or even a pattern.

The rest of this page walks through each stage so you can tell which one you’re actually looking at.

What Can a Single Adverse Event Report Actually Show?

In the United States, the main system for adverse event reports is the FDA’s MedWatch program. It collects voluntary and required reports about problems linked to medicines, medical devices, biologics (which can include some regenerative medicine products), and other regulated products, submitted by patients, family members, or health professionals.

A report by itself can tell you:

• That a specific person experienced a specific problem
• Roughly when it happened in relation to the product or procedure
• Basic details the reporter chose to include, such as symptoms or a product name

A single report cannot tell you:

• Whether the product actually caused the problem, or whether the problem would have happened anyway
• How common the problem is among everyone who used the product
• Whether the report was verified by a clinician or investigator

Reporting is largely voluntary for patients and consumers. That means the number of reports on file is very unlikely to match the true number of people affected. Some problems get reported many times over; others may never get reported at all.

What Can a Pattern of Reports Show That One Report Can’t?

Regulators and researchers watch for patterns, not just individual reports. When many reports describe a similar problem linked to a similar product, that pattern can prompt a closer look, an official safety communication, or a formal investigation. This is one of the real strengths of adverse event reporting systems — they can pick up early warning signals that a single report never could.

For regenerative medicine products specifically, the FDA has warned that reported problems associated with unapproved products have included tumor formation, infections, blindness, and cells traveling to and growing in the wrong part of the body. Those are examples of patterns that led to public safety warnings. They are not a claim that every person who receives such a product will experience these outcomes.

Even a clear pattern has limits. It can tell you a signal exists and deserves attention. On its own, it still can’t tell you how often the problem happens, who is most at risk, or whether some other factor was the real cause.

What Would Actually Count as Proof a Product Is Safe?

Proving a product is safe, or that it causes a specific problem, generally requires controlled research: studies comparing people who received the product with people who didn’t, using consistent methods and enough participants to rule out coincidence. That’s a much higher standard than any single report or collection of reports can meet alone.

“Safe” also isn’t all-or-nothing. Regulatory approval and ongoing safety monitoring reflect a judgment that a product’s known benefits outweigh its known risks for a specific, studied use. A product can be well understood for one use and completely unstudied for another. The FDA has specifically noted that many regenerative medicine products marketed for conditions such as arthritis, back pain, autism, or neurological disease are not FDA-approved for those uses, regardless of how they are marketed.

A Quick If/Then Guide to Reading a Safety Claim

• If you see a single story or one adverse event report, then treat it as one data point worth noting, not evidence the product is dangerous or safe.
• If you see many similar reports described as a “pattern” or a regulator issuing a safety communication, then treat it as a signal worth taking seriously and asking a clinician about — but not yet proof of cause.
• If a claim cites a controlled study with a comparison group, then it’s operating at the level of evidence that can actually support a cause-and-effect statement — check who published it and whether it was peer-reviewed.
• If a claim doesn’t say where its numbers came from at all, then treat it as unverified until you can trace it back to a source like MedWatch or a published study.

A Decision Path for Reading Safety Claims

The next time you see a safety claim, whether it’s reassuring or alarming, walk it through these questions in order.

1. What exactly is being described? A single story, a handful of reports, a formal safety communication, or a published study? Each carries different weight.
2. Is a comparison being made? “12 reports” only means something next to a number of people who used the product and a sense of how that compares to an untreated group.
3. Who is making the claim, and what is the source? A regulator’s safety communication, a peer-reviewed study, and an anonymous post carry very different levels of reliability.
4. Does the claim distinguish “linked to” from “caused by”? Careful sources say a problem was “reported following” a product, not that the product “was proven to cause” it, unless a controlled study backs that up.
5. What would change your mind? If no evidence could make you question the claim, that’s a sign to slow down, regardless of which direction the claim points.

Questions Worth Bringing to a Conversation With a Clinician

This page can’t tell you what to do about a specific procedure. It can help you prepare better questions for the people qualified to advise you.

• Is this product or procedure FDA-approved for my specific condition, or is it being used off-label or without approval?
• What adverse events have been reported for this specific product, and how were they identified?
• Is there controlled research on this product for my condition, or mainly individual reports and testimonials?
• What would happen if I did nothing, or chose a standard, well-studied option instead?
• How would a problem be reported and tracked if I experienced one?

How Do I Report a Problem to the FDA Myself?

If you or your doctor believe you experienced a problem linked to a regenerative medicine product, you can report it directly to the FDA:

• Through the FDA’s MedWatch Adverse Event Reporting program, the agency’s main system for voluntary and required safety reports
• By contacting the FDA’s Office of Compliance and Biologics Quality directly for regenerative medicine and biologics concerns

Reporting matters even if you’re not sure the product was the cause. Reports are part of how patterns get noticed in the first place. Our Editorial Policy explains how we handle sourcing and corrections when new safety information changes what a page should say.

Where to Go From Here

If you want to understand how researchers weigh different kinds of evidence more broadly, our How We Research page explains how we evaluate sources on this site, including why we prioritize regulatory guidance and controlled studies over individual claims. If you’re new to reading regenerative medicine claims in general, Start Here is a good next stop for the basics of research quality and how to evaluate a claim. Our full Medical Disclaimer explains the limits of everything on this site in more detail.

Frequently Asked Questions

Does an FDA adverse event report mean a product is dangerous?

Not by itself. A single report means one person or their doctor described a problem after using a product. It does not establish that the product caused the problem or how often it happens.

Who can file a MedWatch report?

Patients, family members, and health professionals can all submit voluntary reports to the FDA’s MedWatch program. Some reports are also mandatory for manufacturers and certain healthcare facilities.

What has the FDA said about safety problems with regenerative medicine products?

The FDA has warned that reported problems linked to unapproved regenerative medicine products have included tumor formation, infections, blindness, and cells migrating to unintended parts of the body.

Does FDA approval mean a product has no risks?

No. Approval reflects a judgment that a product’s known benefits outweigh its known risks for a specific, studied use — not a commitment of zero risk, and not evidence it’s safe for unapproved uses.

How do I report a problem from a regenerative medicine product?

You can file a report through the FDA’s MedWatch Adverse Event Reporting program, or contact the FDA’s Office of Compliance and Biologics Quality directly.

The Bottom Line

A single adverse event report tells you one thing happened to one person. A pattern of reports can be a genuine warning sign worth taking seriously. Neither one, on its own, proves a product is dangerous or safe. Reading safety information carefully means noticing which of these three things you’re actually looking at, and asking a qualified clinician to help you weigh what it means for your own situation.

Medical Information Disclaimer

This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment recommendations. It is not a substitute for a consultation with a qualified healthcare provider. Do not start, stop, or change any treatment based on this article. If you are experiencing a medical emergency, call your local emergency number immediately. Regenerative Evidence Guide is an independent educational publication and is not affiliated with any regenerative medicine clinic, academy, faculty, or training program formerly associated with this domain.

By Regenerative Evidence Guide Editorial Team. Sources: U.S. Food and Drug Administration, MedWatch Safety Information and Adverse Event Reporting Program; U.S. Food and Drug Administration, Important Patient and Consumer Information About Regenerative Medicine Therapies. Last updated September 8, 2026.